Active Ingredient: Mefenamic acid
For this indication, competent medicine agencies globally authorize below treatments:
For:
Oral, 500 milligrams mefenamic acid, 3 times daily.
It should be taken preferably with or after food.
For:
Rectal, 500 milligrams mefenamic acid, 3 times daily.
For:
Oral, 25 milligrams mefenamic acid per kilogram of body weight, divided daily, over the duration of 7 days.
It is recommended that children under 12 years of age should be given mefenamic acid suspension (50mg/5ml) in the following dosage regime:
Infants over 6 months – 25mg/kg of bodyweight daily in divided doses, or,
6 months to under 2 years – one 5 ml spoonful
2 years to under 5 years – two 5 ml spoonfuls
5 years to under 9 years – three 5 ml spoonfuls
9 years to 12 years – four 5 ml spoonfuls
Doses may be repeated as necessary, up to three times daily.
Therapy should not be continued for longer than 7 days in children.
Mefenamic acid suspension should be taken preferably with or after food.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
